Z-2339-2017Class II
VIDAS Testosterone, Ref 30418
bioMerieux, Inc. / initiated 2017-05-15 / Terminated
bioMerieux, Inc. began a recall of VIDAS Testosterone, Ref 30418 on . FDA classified it as Class II and gives the reason as "Complaints were received from customers observing falsely overestimate results or external quality control higher results than expected when performing tests with VIDAS Testosterone". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-2339-2017
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- bioMerieux, Inc.
- Product
- VIDAS Testosterone, Ref 30418
- Product code
- CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone
- Reason for recall
- Complaints were received from customers observing falsely overestimate results or external quality control higher results than expected when performing tests with VIDAS Testosterone.
- FDA root cause
- Under Investigation by firm
- Action
- An Urgent Product Safety Notice was sent on 5/15/2017 to consignees. The Notice requested that they discontinue use and discard any remaining inventory of the product, and to identify any possible falsely over estimated results and determine appropriate actions if relevant. The Notice also included a response form to be returned to Biomerieux.
- Quantity in commerce
- 742
- Distribution
- AR, CA, CO, GA, IL, IA, MI, MN, MT, NY, OK, TN, TX, WY, Columbia, Costa Rica, El Salvador, France, Hong Kong, Jordan, Nicaragua, Russian Fed., Sri Lanka, Sweden, Ukraine
- Product codes and lots
- Lots 1004878310 & 1005001080
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2339-2017 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
